EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

12.20.09

The Great Pharmaceutical Patent Hoax and the Gates Pharmaceutical Patent Investments

Posted in Bill Gates, Microsoft, Patents at 7:40 am by Dr. Roy Schestowitz

Gates Foundation logo

Summary: Why the pharmaceutical industry does not need patents and a reminder that Bill Gates invests heavily in these patents

A FEW days ago we promised to say something about pharmaceutical patents, which are some of the most evil and unethical patents out there (see Novartis for example [1, 2, 3, 4] as it is a top lobbyist for patents, just like Microsoft).

USPTOIn our previous explorations of the Gates Foundation we showed that it was a multi-billion dollar investor in pharmaceutical patents [1, 2, 3, 4, 5, 6, 7, 8]. There is an unethical issue here — an issue which we wrote about in recent days [1, 2].

Here is a long and interesting analysis of the Gates Foundation, aptly titled “rich out for the poor”

It concludes with:

I love it when everything comes together for the good of those who love the poor. This is the climate change I’d like to see enveloping the whole creative CGIAR.

Speaking of climate change, the Gates Foundation denies global warming and so do other patent maximalists like Gene Quinn (a patent maximalist who lobbies very hard for software patents). He is calling Global Warming a “Fraud” in order to defend patents which prevent the fight against pollution and other harms to the environment. Well, patents and ethics never mixed well.

As we promised at the start, we wish to also rebut the perception that patents can save lives. It’s the propaganda used by the big pharmaceutical companies and it is contradicted by one of the first answers in the following good talk. [thanks to our reader Fewa for pointing this out]

The claim that patents are vital for the pharmaceutical industry ignores the fact that almost all the research is publicly funded and from the overall income only about 15% is diverted towards research and discovery. About 40% goes towards manufacturing and the rest is profit and marketing (sometimes telling people there is something wrong with them so that they buy drugs they do not require and may even have nasty side effects and unknown long-term ramifications). Research prioritises proftable products like those which rich people will buy (e.g. creams against wrinkles), as opposed to drugs that save lives of poor people who can hadly pay and thus are not in the shareholders’ interest.

One of our readers, The Mad Hatter, added the following two references yesterday:

1. Big Pharma’s Crime Spree

Big Pharma’s Crime Spree

Rather than having a deterrent effect, the number of Big Pharma high profile criminal settlements is increasing and the settlements are getting bigger. BIG PHARMA’S CRIME SPREE is a riveting report by David Evans in the current issue of Bloomberg Markets Magazine relying on recent criminal legal settlements. It leaves no doubt about the fact that Big Pharma’s business practices are defined by criminal activities.

2. Possible MS Breakthrough Neglected By American Media

Possible MS [Multiple Sclerosis] Breakthrough Neglected By American Media

Folks who suffer from Multiple Sclerosis are not really a rowdy bunch. Activism and outrage are hard to muster for the chronically fatigued. But since Thanksgiving, people with MS and their loved ones have gone all ACT-UP 2.0.

That is, the past few weeks have seen a surge in online activity within the MS community – as bloggers, vloggers and forum posters are calling one another to action in response to the lack of response to what many perceive to the scientific breakthrough they’ve been waiting for.

There are even more heinous crimes from this whole industry. Apart from experimentation with poor populations (drug testing in Africa for example*), just a few weeks ago there were reports which revealed that the big pharmaceutical companies paid makers of generic drugs to close shop and stop competing so that affordable drugs are taken off the market shelves (and thus kill an already-impoverished population). Sounds like Microsoft, doesn’t it? Nobel Prize-winning economist Joseph Stiglitz made it rather clear that this is a common problem, not the exception.

There are many reasons to argue that the pharmaceutical industry does not need patents. It is trying to defend and sometimes shore up an old business model, whereas others in this field have already moved on to paradigms of sharing (see the references here). It is less wasteful, so progress is more rapid and the customer/patient benefits the most.
___
* To give an extreme example, the United States used the population of south Vietnam as a “control group” after resorting to chemical warfare.

“Gates has created a huge blood-buying operation that only cares about money, not about people.”

AIDS organisation manager, December 2009 (New York Times)

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. Links 25/5/2019: Wine 4.9 Released, FreeBSD 11.3 Beta, Telegram Launches Fift

    Links for the day



  2. Links 24/5/2019: PostgreSQL 12 Beta 1 and Rust 1.35 Released

    Links for the day



  3. EPO Strikes Further Diminish Chances of UPC Ever Materialising (in Any Shape or Form)

    The EPO crumbles under the weight of its own corruption while an increasingly-insane Team UPC pretends all remains normal and a patent trolls-friendly system is ready to take off



  4. EPO Allegedly Becoming Insolvent (Pretext for Cuts), So Staff Gets Punished While Management Takes the Jackpot

    The corporate 'logic' at the EPO follows the "shareholders' value" propaganda line as if the EPO is a private company looking to maximise revenue rather than serve the public



  5. EPO President Still Not Obeying Courts' Rulings

    Federation of International Civil Service Associations (FICSA) sent a message to António Campinos yesterday (the same day SUEPO publicly made a call for strike)



  6. António Campinos Has Run Out of Time and EPO Staff is Going on Strike (Skipping Mere Protests)

    European Patent Office strikes are to resume; as SUEPO recently put it, people have come to accept that EPO leadership has not really changed and none of the underlying issues is being tackled



  7. Links 23/5/2019: Elisa 0.4.0, OpenSUSE Leap 15.1 Released

    Links for the day



  8. Links 22/5/2019: Mesa 19.0.5, Huawei and GNU/Linux, Curl 7.65.0, End of Antergos, Tails 3.14, ownCloud Server 10.2, Firefox 67.0

    Links for the day



  9. Quality of Patents is Going Down the Drain and Courts Have Certainly Noticed

    Uncertainty or lack of confidence in the patent system has reached appalling levels because heads of patent offices are just striving to grant as many patents as possible, irrespective of the underlying law



  10. EUIPO and EPO Abuses Growingly Inseparable

    'Musical chairs' at CEIPI and the EPO/EUIPO (Battistelli, Archambeau, Campinos) as well as joint reports never fail to reveal the extent to which EPO abuses are spreading



  11. Links 21/5/2019: China's GAFAM Exit, DragonFlyBSD 5.4.3

    Links for the day



  12. Links 20/5/2019: Linux 5.2 RC1, LibreOffice 6.3 Alpha, DXVK 1.2.1, Bison 3.4 Released

    Links for the day



  13. South Korea's Government Will Show If Microsoft Loves Linux or Just Attacks It Very Viciously Like It Did in Munich

    Microsoft's hatred of all things GNU/Linux is always put to the test when someone 'dares' use it outside Microsoft's control and cash cows (e.g. Azure and Vista 10/WSL); will Microsoft combat its longstanding urge to corrupt or oust officials with the courage to say "no" to Microsoft?



  14. Links 19/5/2019: KDE Applications 19.04.1 in FlatHub and GNU/Linux Adoption

    Links for the day



  15. The War on Patent Quality

    A look at the EPO's reluctance to admit errors and resistance to the EPC, which is its very founding document



  16. Watchtroll, Composed by Patent Trolls, Calls the American Patent System “Corrupt”

    Another very fine piece from Watchtroll comes from very fine patent trolls who cheer for Donald Trump as if he's the one who tackles corruption rather than spreading it



  17. Unified Patent Court Won't Happen Just Because the Litigation Microcosm Wants It

    Unified Patent Court (UPC) hopefuls are quote-mining and cherry-picking to manufacture the false impression that the UPC is just around the corner when in reality the UPC is pretty much dead (but not buried yet)



  18. Links 17/5/2019: South Korea's GNU/Linux Pivot, Linux 5.1.3

    Links for the day



  19. Q2 Midterm Weather Forecast for EPOnia, Part 4: Happy Birthday to the Kötter Group?

    This year the Kötter Group commemorates the 85th anniversary of its existence. But is it really a cause for celebration or would a less self-congratulatory approach be more fitting? And does it create the risk that a routine tendering exercise at the EPO will turn into Operation Charlie Foxtrot?



  20. Links 16/5/2019: Cockpit 194, VMware Acquires Bitnami, Another Wine Announcement and Krita 4.2.0 Beta

    Links for the day



  21. The EPO's Key Function -- Like the UPC's Vision -- Has Virtually Collapsed

    The EPO no longer issues good patents and staff is extremely unhappy; but the Office tries to create an alternate (false) reality and issues intentionally misleading statements



  22. Stanford's NPE Litigation Database Makes a Nice Addition in the Fight Against Software Patent Trolls

    As the United States of America becomes less trolls- and software patents-friendly (often conflated with plaintiff (un)friendliness) it's important to have accurate data which documents the numbers and motivates better policy; The NPE (troll) Litigation Database is a move towards that and it's free to access/use



  23. Q2 Midterm Weather Forecast for EPOnia, Part 3: “Ein kritikwürdiges Unternehmen”

    A brief account of some further controversies in which the Kötter Group has been involved and its strained relations with German trade unions such as Verdi



  24. EPO Had a Leakage Problem and Privacy of Stakeholders Was Compromised, Affecting at Least 100 Cases

    The confidentiality principle was compromised at the EPO and stakeholders weren't told about it (there was a coverup)



  25. Links 15/5/2019: More Linux Patches and More Known Intel Bugs

    Links for the day



  26. False Hope for Patent Maximalists and Litigation Zealots

    Patent litigation predators in the United States, along with Team UPC in Europe, are trying to manufacture optimistic predictions; a quick and rather shallow critical analysis reveals their lies and distortions



  27. The Race to the Bottom of Patent Quality at the EPO

    The EPO has become more like a rubber-stamper than a patent office — a fact that worries senior staff who witnessed this gradual and troublesome transition (from quality to raw quantity)



  28. Q2 Midterm Weather Forecast for EPOnia, Part 2: Meet the Kötters

    An introduction to the Kötter Group, the private security conglomerate which is lined up for the award of a juicy EUR 30 million contract for the provision of security services at the EPO



  29. Links 14/5/2019: Red Hat Satellite 6.5, NVIDIA 430.14 Linux Driver and New Security Bug (MDS)

    Links for the day



  30. Links 14/5/2019: GNU/Linux in Kerala, DXVK 1.2, KDE Frameworks 5.58.0 Released

    Links for the day


RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

Recent Posts